about
Using routine data to improve palliative and end of life care.CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cellsReversal of English trend towards hospital death in dementia: a population-based study of place of death and associated individual and regional factors, 2001-2010.The value of uncertainty in critical illness? An ethnographic study of patterns and conflicts in care and decision-making trajectories.'It doesn't do the care for you': a qualitative study of health care professionals' perceptions of the benefits and harms of integrated care pathways for end of life careDissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland.The changing demographics of inpatient hospice death: Population-based cross-sectional study in England, 1993-2012.Reporting of clinically diagnosed dementia on death certificates: retrospective cohort study.Developing a model of short-term integrated palliative and supportive care for frail older people in community settings: perspectives of older people, carers and other key stakeholders.Factors Associated with Transition from Community Settings to Hospital as Place of Death for Adults Aged 75 and Older: A Population-Based Mortality Follow-Back SurveyDo patients need to know they are terminally ill? Yes.Leaky pipeline, gender bias, self-selection or all three? A quantitative analysis of gender balance at an international palliative care research conference.Autoimmune neurological disease after cardiac surgery.Supporting relatives and carers at the end of a patient's life.The changing demographics of inpatient hospice death: population-based, cross-sectional study in England, 1993-2012.Evidence-based policy in palliative care: time to learn from our mistakes.Easing the transition: acceptability and safety of the 50-mL syringe pump in the acute general hospital setting.Is end-of-life care a priority for policymakers? Qualitative documentary analysis of health care strategiesA Psychometric Validation of Two Brief Measures to Assess Palliative Need in Patients Severely Affected by Multiple SclerosisPlace of death, and its relation with underlying cause of death, in Parkinson’s disease, motor neurone disease, and multiple sclerosis: A population-based studyResearch into end-of-life cancer care—investment is neededIncreasing the value of research in palliative careThe Liverpool Care Pathway: benefit or harm?Care of the dying patient: art or science?Caring for a dying patient in hospitalEnd-of-life communication: let’s talk about deathThe Liverpool care pathway: a cautionary taleBilateral Palmar Contractures as a Paraneoplastic Syndrome in Primary Peritoneal CarcinomaSocioeconomic position and use of healthcare in the last year of life: A systematic review and meta-analysisSpace for intuition - the 'Surprise'-Question in haemato-oncology: Qualitative analysis of experiences and perceptions of haemato-oncologistsEmpowering Better End-of-Life Dementia Care (EMBED-Care): A mixed methods protocol to achieve integrated person-centred care across settingsResponse and role of palliative care during the COVID-19 pandemic: A national telephone survey of hospices in ItalyThe palliative care needs of adults with intellectual disabilities and their access to palliative care services: A systematic review
P50
Q31050524-DB03EFE1-47FE-4EED-B0E6-A3E930757CE0Q34480618-906F934B-D9C5-4CC6-B724-C8E855690774Q35130816-5BA872EF-F810-4022-8F37-31F19532C7A0Q35918616-AFE43BF3-A0C5-4369-9009-9BD9C19721C6Q36081075-F079E2BE-82F4-47E5-9D30-B59420ECC760Q36117022-2F208D15-D21F-4A14-8D3C-8819AA492E4AQ36376807-EDBCBF8D-A41C-494B-BE95-CF489F156A9AQ37264794-21074684-402E-4AA4-962A-DE13D82C1E4AQ37409302-160E4EE3-8E76-41E3-9C6A-CCA9A4EEFD13Q37663953-1E0AC0CF-2003-41EC-8623-A1DEF7FD4F34Q38101460-79788A83-B2FA-493F-8721-3C46B02EFDE2Q38922373-2124CD65-5006-4A68-B6DF-3D90120B1230Q43029622-C87F10F1-C295-47CC-8776-AC5FFCED0D6CQ47335028-D7D76241-DE75-4DFA-8AF9-6B4F15693576Q48020276-07DCC929-9E66-41BD-84C9-8F09B8FB9B25Q51761252-037FD0D2-A9BD-41BA-91E5-D653AB64CEBFQ53651076-5E9B35A6-FEE4-48EE-BF75-84ADC95C4483Q57144684-B24B7A3E-767E-4662-A1B4-2FAB9075B2D0Q57495070-7EE2DB0A-07FB-404C-8831-D81ADAAE1EE9Q57495138-F253B872-22C7-4B72-AF2A-B56A2E4729C0Q57495214-2D92B1CB-74E1-4193-9F7D-00B37DBB4A46Q60733326-57F68ECD-B996-407B-95A7-1BC98124AB5EQ60733331-76B22A06-6901-4941-B5F2-0CA35F9F57E8Q60733334-558DD551-F46A-48B0-AF92-D758E95377E8Q60733337-007FC63D-3FD3-4B39-8893-DD09056F7630Q60733339-83E0D707-9097-4C2F-AB5E-8ADA0C06075BQ60733340-A7B1C8AD-0D5C-4D6F-AD09-BB7704213A5CQ60733356-49A991D2-46A3-47DD-9F1E-3F81E2E88EF1Q64098094-B980717A-1C38-48F1-AD0D-5182EFCC5ECCQ91246160-4F8A4C77-AFEB-4156-9E57-7F93948B9C52Q92110567-81F1A32B-3CFB-4B31-851C-C7182DF55B08Q94458435-0BED92F7-43E1-4565-9072-4A56182970C4Q96582966-2D2BC82E-863D-40F6-9A39-2F8466936878
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Katherine Sleeman
@ast
Katherine Sleeman
@en
Katherine Sleeman
@es
Katherine Sleeman
@nl
Katherine Sleeman
@sl
type
label
Katherine Sleeman
@ast
Katherine Sleeman
@en
Katherine Sleeman
@es
Katherine Sleeman
@nl
Katherine Sleeman
@sl
prefLabel
Katherine Sleeman
@ast
Katherine Sleeman
@en
Katherine Sleeman
@es
Katherine Sleeman
@nl
Katherine Sleeman
@sl
P106
P21
P31
P496
0000-0002-9777-4373